Foghorn Therapeutics Inc (NASDAQ: FHTX) is 0.64% higher on its value in year-to-date trading and has touched a low of $2.94 and a high of $10.25 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The FHTX stock was last observed hovering at around $4.79 in the last trading session, with the day’s loss setting it -0.04%.
Currently trading at $4.75, the stock is 9.21% and 14.03% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.2 million and changing -0.84% at the moment leaves the stock -17.85% off its SMA200. FHTX registered -9.52% loss for a year compared to 6-month loss of -10.38%.
The stock witnessed a 12.83% gain in the last 1 month and extending the period to 3 months gives it a 6.98%, and is 3.71% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.74% over the week and 3.92% over the month.
Foghorn Therapeutics Inc (FHTX) has around 112 employees, a market worth around $264.77M and $23.50M in sales. Profit margin for the company is -342.23%. Distance from 52-week low is 61.30% and -53.66% from its 52-week high.
The EPS is expected to grow by 20.09% this year
The shares outstanding are 55.72M, and float is at 27.90M with Short Float at 3.94%.
The top institutional shareholder in the company is FLAGSHIP PIONEERING INC. with over 12.67 million shares valued at $72.88 million. The investor’s holdings represent 24.5716 of the FHTX Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 6.38 million shares valued at $36.7 million to account for 12.3754 of the shares outstanding. The other top investors are BVF INC/IL which holds 5.3 million shares representing 10.2791 and valued at over $30.49 million, while DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) holds 4.8827 of the shares totaling 2.52 million with a market value of $14.48 million.
Foghorn Therapeutics Inc (FHTX) Insider Activity
The most recent transaction is an insider sale by Costa Carlos, the company’s Chief People Officer. SEC filings show that Costa Carlos sold 35,756 shares of the company’s common stock on Sep 20 ’24 at a price of $10.04 per share for a total of $0.36 million. Following the sale, the insider now owns 0.0 shares.
Foghorn Therapeutics Inc disclosed in a document filed with the SEC on Sep 23 ’24 that Costa Carlos (Chief People Officer) sold a total of 857 shares of the company’s common stock. The trade occurred on Sep 23 ’24 and was made at $10.17 per share for $8716.0. Following the transaction, the insider now directly holds 0.0 shares of the FHTX stock.
Still, SEC filings show that on Sep 18 ’24, Costa Carlos (Chief People Officer) disposed off 11,574 shares at an average price of $10.05 for $0.12 million. The insider now directly holds 0 shares of Foghorn Therapeutics Inc (FHTX).
